Who
Zackary S. Irani
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Biomerica.
In numbers
- Trades disclosed
- 101
- Buys
- 38
- Sells
- 0
- Bought
- $236K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 31 May 2006
- Last trade
- 26 Aug 2026
- Last filed
- 27 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 26 Aug 2026filed 27 Aug 2026 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $50K31,250 at $1.60 | filing |
| 26 Aug 2026filed 27 Aug 2026 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $50K31,250 at $1.60 | filing |
| 12 Dec 2025filed 31 Dec 2025 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Code A | —52,500 at $0.00 | filing |
| 13 Dec 2024filed 17 Dec 2024 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Code A | $78K250,000 at $0.31 | filing |
| 13 Dec 2023filed 14 Dec 2023 | BMRA Biomericaoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —155,000 | filing |
| 25 May 2023filed 26 May 2023 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $310200 at $1.55 | filing |
| 24 May 2023filed 26 May 2023 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $805500 at $1.61 | filing |
| 12 May 2023filed 12 May 2023 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $1,9891,700 at $1.17 | filing |
| 10 May 2023filed 12 May 2023 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $635500 at $1.27 | filing |
| 9 May 2023filed 10 May 2023 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $417300 at $1.39 | filing |
| 4 May 2023filed 5 May 2023 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $1,3601,000 at $1.36 | filing |
| 28 Apr 2023filed 1 May 2023 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $2,4121,800 at $1.34 | filing |
| 27 Apr 2023filed 1 May 2023 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $3,4062,600 at $1.31 | filing |
| 26 Apr 2023filed 27 Apr 2023 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $8,8207,000 at $1.26 | filing |
| 20 Apr 2023filed 11 Dec 2023 | BMRA Biomericaoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —105,000 | filing |
| 25 Jan 2023filed 26 Jan 2023 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $5,1301,800 at $2.85 | filing |
| 24 Jan 2023filed 25 Jan 2023 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Bought | $5,6202,000 at $2.81 | filing |
| 9 Dec 2021filed 10 Dec 2021 | BMRA Biomericaoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —100,000 | filing |
| 10 Dec 2020filed 11 Dec 2020 | BMRA Biomericaoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —78,616 | filing |
| 28 Feb 2020filed 2 Mar 2020 | BMRA BiomericaDiagnostics & Labs | SEC FORM 4 Code J | $224K78,431 at $2.85 | filing |
News
Contrasting Biomerica (NASDAQ:BMRA) and Envoy Medical (NASDAQ:COCH)BMRA · themarketsdaily.com · 19 Oct 2026Financial Comparison: TerrAscend (OTCMKTS:TSNDF) versus Biomerica (NASDAQ:BMRA)BMRA · dailypolitical.com · 18 Oct 2026Biomerica Reports $1.265 Million in Fiscal First-Quarter Sales and $1.232 Million LossBMRA · econotimes.com · 17 Oct 2026
0 headlines in the last 90 days name Zackary S. Irani; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.